(R)-tert-Butyl (2,5-dioxopyrrolidin-3-yl)carbamate

Catalog No.: 
ACEVMK654
CAS No.: 
163929-77-9
Molecular Formula: 
C9H14N2O4
Molecular Weight: 
214.22
(R)-tert-Butyl (2,5-dioxopyrrolidin-3-yl)carbamate structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
100mg95%$90.00In stockInquiry
250mg95%$205.00In stockInquiry
1g95%$812.00In stockInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name(R)-tert-Butyl (2,5-dioxopyrrolidin-3-yl)carbamate
IUPAC Nametert-butyl (R)-(2,5-dioxopyrrolidin-3-yl)carbamate
MDL No.MFCD19053240
Molecular FormulaC9H14N2O4
Molecular Weight214.22
SMILESO=C(OC(C)(C)C)N[C@H](C1)C(NC1=O)=O
InChI KeyADNLCKRUARJETQ-RXMQYKEDSA-N
Synonym(R)-tert-butyl 2,5-dioxopyrrolidin-3-ylcarbamate;Carbamic acid, (2,5-dioxo-3-pyrrolidinyl)-, 1,1-dimethylethyl ester, (R)- (9CI);Tert-butyl (R)-(2,5-dioxopyrrolidin-3-yl)carbamate
CAS No.163929-77-9

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H315-H319
Precautionary Statement(s)
P264-P280-P302+P352-P305+P351+P338-P332+P313-P337+P313-P362

Synthetic Route by SureRoute

1. ACEVMK654 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACEVMK654 route product structure diagram
    ACEVMK654163929-77-9In Stock
Inquiry

2. ACEVMK654 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACEVMK654 route product structure diagram
    ACEVMK654163929-77-9In Stock
Inquiry

3. ACEVMK654 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACEVMK654 route product structure diagram
    ACEVMK654163929-77-9In Stock
Inquiry

Comments (0)